Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Australian Government IP Australia
Additional fields:

Trade mark 2528171

Words TERNS
Image
Image description
Status registered: Registered/protected
Priority date 09 Sep 2024 (Convention)
Classes 5, 42
Kind Word
Dates
Renewal due 06 Mar 2035
Registration advertised / published 25 Aug 2025
Entered on Register 25 Aug 2025
Acceptance advertised / published 16 Jun 2025
Acceptance 16 Jun 2025
Filing 06 Mar 2025
Registered from 06 Mar 2025

Owner Address for service
Terns Pharmaceuticals, Inc.
PHILLIPS ORMONDE FITZPATRICK

Goods & Services
Class 5: Pharmaceutical preparations, namely, small-molecule drugs; Pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; Peptides for pharmaceutical purposes
Class 42: Pharmaceutical and biologic development services, namely, development of small-molecule drugs for use in humans; Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; Research and development services in the field of pharmaceutical and biologic preparations; Research and development services in the field of oncology-related diseases and disorders; Research and development services in the field of metabolic-related diseases and disorders; Research and development services in the field of endocrine-related diseases and disorders; Research and development services in the fields of diabetes and obesity-related diseases and disorders; Research and development services in the field of peptide pharmaceutical preparations; Providing medical and scientific research information in the field of small-molecule drugs; Providing medical and scientific research information in the field of clinical trials and post-market trials; Providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders

Convention details
Date 09 Sep 2024
Number 98/740,258
Country UNITED STATES OF AMERICA
Goods & Services
Class 5:
Pharmaceutical preparations, namely, small-molecule drugs;Pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders;Pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders;Pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders;Pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders;Peptides for pharmaceutical purposes
Class 42:
Pharmaceutical and biologic development services, namely, development of small-molecule drugs for use in humans;Research and development services in the fields of diabetes and obesity-related diseases and disorders;Research and development services in the field of peptide pharmaceutical preparations;Providing medical and scientific research information in the field of small-molecule drugs;Providing medical and scientific research information in the field of clinical trials and post-market trials;Providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders;Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders;Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders;Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders;Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders;Research and development services in the field of pharmaceutical and biologic preparations;Research and development services in the field of oncology-related diseases and disorders;Research and development services in the field of metabolic-related diseases and disorders;Research and development services in the field of endocrine-related diseases and disorders

Indexing constituents
Word Image